Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: MIZAR THERAPEUTICS INC.
Awarding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Funding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Period of performance: 2025-09-29 to 2027-09-28
Current total value of award: $899995
Description: SBIR PHASE II - MIZAR S/TAR HIGH-THROUGHPUT PLATFORM FOR IDENTIFICATION OF SENESCENCE ALTERING THERAPEUTICS